Indivior Pharmaceuticals Inc
INDV
Clasificación en acciones
#4006
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged... Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Precio por acción
$32.56
Última sincronización: 2026-10-16
Capitalización bursátil
$4.06B
Cambio (1 día)
-3.15%
Cambio (1 año)
33.01%
País
US
Comercio Indivior Pharmaceuticals Inc (INDV)
Categoría
Healthcare
EPS de Indivior Pharmaceuticals Inc (INDV)
EPS a fecha de June 2026 TTM: $2.84
Según los últimos informes financieros y el precio de las acciones de Indivior Pharmaceuticals Inc, el EPS actual de la empresa (TTM) es $2.84. Al final del año 2023, la empresa tenía un EPS de $0.01 un aumento con respecto a al EPS de 2022, que fue de $-0.37.
Historial de EPS de Indivior Pharmaceuticals Inc desde 2016 hasta 2026
EPS al final de cada año
| Año | EPS | Cambiar |
|---|---|---|
| 2026 (TTM) | $2.84 | 14,100.00% |
| 2024 | $0.02 | 3.42% |
| 2023 | $0.01 | -103.95% |
| 2022 | $-0.37 | -126.81% |
| 2021 | $1.38 | -227.78% |
| 2020 | $-1.08 | -213.68% |
| 2019 | $0.95 | -47.51% |
| 2018 | $1.81 | 330.95% |
| 2017 | $0.42 | 90.91% |
| 2016 | $0.22 | 0.00% |
EPS de empresas similares o competidoras
| Empresa | EPS | Diferencia de EPS | País |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | -80.41% |
IN
|
